Cytosorbents
CTSO
#9872
Rank
A$63 M
Marketcap
A$1.00
Share price
-0.30%
Change (1 day)
-41.20%
Change (1 year)

Earnings for Cytosorbents (CTSO)

Earnings in 2025 (TTM): -A$20.21 Million

According to Cytosorbents's latest financial reports the company's current earnings are A$36.97 Million. In 2024 the company made an earning of -A$33.98 Million, an increase over its 2023 earnings that were of -A$43.84 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cytosorbents from 2006 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$20.21 Million-40.53%
2024 -A$33.98 Million-22.49%
2023 -A$43.84 Million-13.52%
2022 -A$50.69 Million34.04%
2021 -A$37.82 Million182.17%
2020 -A$13.41 Million-55.97%
2019 -A$30.44 Million14.17%
2018 -A$26.66 Million95.14%
2017 -A$13.67 Million-22.32%
2016 -A$17.59 Million39.1%
2015 -A$12.65 Million-12.89%
2014 -A$14.52 Million89%
2013 -A$7.68 Million26.65%
2012 -A$6.07 Million-26.02%
2011 -A$8.2 Million-288.45%
2010 A$4.34 M-4.17%
2009 A$4.53 M-287.19%
2008 -A$2.43 Million-47.12%
2007 -A$4.59 Million41.78%
2006 -A$3.24 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Meridian Bioscience
VIVO
A$82.98 M-537.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Hologic
HOLX
A$1.19 B-6,397.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Boston Scientific
BSX
A$4.88 B-25,894.75%๐Ÿ‡บ๐Ÿ‡ธ USA